APR 17, 2018 12:51 PM PDT

New Experimental Model for ALS and MS Immunotherapies

WRITTEN BY: Kara Marker

A new mouse model allows researchers to study the impact of immune cell function in the brain on diseases like amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). With the hope of developing new immunotherapies for these diseases, researchers from the Karolinska Institutet use the model in a new study.

MRI of someone with amyotrophic lateral sclerosis. Credit: Dr. Frank Gaillard

Immune cells called monocytes travel through to blood into the brain and damage neurons and the myelin sheath, a protective layer of tissue that promotes the transmission of nerve impulses. In ALS, neurons controlling voluntary muscle movement are affected. These are the neurons responsible for chewing, walking, and talking. Over time, these neurons deteriorate completely. Most people with ALS die from respiratory failure three to five years after they first develop symptoms.

With MS, an autoimmune disease and the most common neurological disease affecting young adults, the immune system mistakenly attacks the myelin sheath, affecting neurons in the brain and spinal cord. People with MS experience numbness, weakness, and pain in the arms and legs, vision loss, tremors, fatigue, dizziness, bowel and bladder dysfunction. Over 400,000 people in the United States and 2.5 million people across the globe are affected by MS.

Macrophages are phagocytic cells, which means they serve the immune system by engulfing and digesting bacteria and other unfriendly objects they come across. Macrophages in the brain, called microglia, specialize in function as directed by the cytokine TGF-β. Can TGF-β prevent monocytes from becoming harmful, instead alter them to function positively like the microglia?

"We already knew that TGF-β is produced in the brain and is important for giving microglia their specialised functions," explained first author Harald Lund. "So we figured that monocytes should also respond to TGF-β when they enter the brain. We were curious to see what would happen if the monocytes lost the ability to respond to TGF-β."

Using the new model, researchers removed the mice’s microglia. This resulted in monocytes rushing into the brain and spinal cord, mimicking the activity of microglia and causing no pathological symptoms. But when researchers inhibited TGF-β activity, the monocytes started to destroy the myelin in the spinal cord, and a lethal neurodegenerative disease developed. The symptoms of that disease looked just like ALS.

In the future, researchers could use a similar model to test more aspects of diseases like ALS and MS, as well as test new potential immunotherapies.

"There are many deadly neurodegenerative diseases in humans, but a lack of experimental models for developing new immunotherapies," explained Bob Harris, PhD. "This new disease model will be a valuable addition to our research programme and we hope that the next study will result in a new, effective therapy."

The present study was published in the journal Nature Immunology.

Sources: Karolinska Institutet, Discovery MS, Mayo Clinic, National Institute of Neurological Disorders and Stroke

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 29, 2019
Drug Discovery & Development
SEP 29, 2019
Researchers Can Now Reverse Skin Cancer
Ten years ago, just 5% of people with advanced melanoma (skin cancer) lived more than five years after being diagnosed. Now however, researchers from the I...
OCT 19, 2019
Neuroscience
OCT 19, 2019
Autism May be Linked to an Immune Disorder
Until now, diagnosis for autism spectrum disorder have relied on behavioral assessments looking for symptoms including poor social and communication skills...
DEC 10, 2019
Immunology
DEC 10, 2019
T Cell Subset Uniquely Equipped to Target IBD
A specialized form of T cell emerges as a new focus for gastrointestinal health research, specifically in the context of inflammatory bowel disease (IBD) f...
JAN 28, 2020
Immunology
JAN 28, 2020
Infectious Parasite Manipulates the Immune System to Survive
Toxoplasma gondii suppresses the immune system of the hosts it infects – human or otherwise – just enough to survive, thrive, and move on to mo...
FEB 10, 2020
Immunology
FEB 10, 2020
Measles infections can give the immune system amnesia
The immune system detects the presence of invading microbes that it recognizes from previous infections, and initiates a full-blown immune response. New re...
FEB 07, 2020
Neuroscience
FEB 07, 2020
Eating Fruits and Vegetables May Lower Alzheimer's Risk
New research has found that flavonols, a large class of compounds present in many fruits and vegetables, may be linked to a lower risk of developing Alzhei...
Loading Comments...